Literature DB >> 19211765

Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Qian Wang1, Alan Kennedy, Papia Das, Pauline B McIntosh, Steven A Howell, Erin R Isaacson, Steven A Hinz, Clare Davy, John Doorbar.   

Abstract

The E1--E4 protein of human papillomavirus type 16 (HPV16) causes cytokeratin reorganization in the middle and upper epithelial layers and is thought to contribute to multiple facets of the virus life cycle. Although little is known as to how HPV16 E1--E4 (16E1--E4) functions are controlled following the first expression of this protein, the finding that low-risk E1--E4 proteins can be phosphorylated in vivo suggests an important role for kinases. Here, we show that 16E1--E4 is phosphorylated by cyclin-dependent kinase 1 (CDK1) and CDK2, extracellular signal-regulated kinase (ERK), protein kinase A (PKA), and PKC alpha, with CDK1/2 serine 32 and ERK threonine 57 phosphorylations representing the two primary events seen in cells in cycle. Interestingly, T57 phosphorylation was found to trigger a structural change in the 16E1--E4 protein that compacts the central fold region, leading to an increase in 16E1--E4 stability and overall abundance in the cell. When compared to wild-type 16E1--E4, a T57D phosphomimic was found to have greatly enhanced keratin-binding ability and an ability to modulate the binding of the unphosphorylated form, with keratin binding protecting the T57-phosphorylated form of 16E1--E4 from proteasomal degradation. In HPV16 genome-containing organotypic rafts, the T57-phosphorylated form was specifically detected in the intermediate cell layers, where productive infection occurs, suggesting that T57 phosphorylation may have a functional role at this stage of the viral life cycle. Interestingly, coexpression with 16E5 and ERK activation enhanced T57 phosphorylation, suggesting that E1--E4 and E5 may work together in vivo. Our data suggest a model in which the expression of 16E5 from the major E1--E4-E5 mRNA promotes T57 phosphorylation of E1--E4 and keratin binding, with dephosphorylation occurring following the switch to late poly(A) usage. Other forms of E1--E4, with alternative functional roles, may then increase in prevalence in the upper layers of the epithelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211765      PMCID: PMC2663250          DOI: 10.1128/JVI.02063-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS.

Authors:  B L Allen-Hoffmann; S J Schlosser; C A Ivarie; C A Sattler; L F Meisner; S L O'Connor
Journal:  J Invest Dermatol       Date:  2000-03       Impact factor: 8.551

2.  Human Papillomavirus. Introduction.

Authors:  E M de Villiers
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

3.  Regulation of the human papillomavirus oncoproteins by differential phosphorylation.

Authors:  P Massimi; D Pim; C Kühne; L Banks
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

4.  Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.

Authors:  T Furuno; N Hirashima; S Onizawa; N Sagiya; M Nakanishi
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

5.  Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.

Authors:  C Kühne; D Gardiol; C Guarnaccia; H Amenitsch; L Banks
Journal:  Oncogene       Date:  2000-11-30       Impact factor: 9.867

6.  The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes.

Authors:  K Crusius; I Rodriguez; A Alonso
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

7.  The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases.

Authors:  Bo Zhou; Zhi-Xin Wang; Yu Zhao; David L Brautigan; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

8.  The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus.

Authors:  J Doorbar; R C Elston; S Napthine; K Raj; E Medcalf; D Jackson; N Coleman; H M Griffin; P Masterson; S Stacey; Y Mengistu; J Dunlop
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  Paranemin and the organization of desmin filament networks.

Authors:  S C Schweitzer; M W Klymkowsky; R M Bellin; R M Robson; Y Capetanaki; R M Evans
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

10.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more
  19 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Phosphorylation of yeast phosphatidylserine synthase by protein kinase A: identification of Ser46 and Ser47 as major sites of phosphorylation.

Authors:  Hyeon-Son Choi; Gil-Soo Han; George M Carman
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

4.  E1--E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium.

Authors:  Pauline B McIntosh; Peter Laskey; Kate Sullivan; Clare Davy; Qian Wang; Deborah J Jackson; Heather M Griffin; John Doorbar
Journal:  J Cell Sci       Date:  2010-07-27       Impact factor: 5.285

5.  Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.

Authors:  Qingming Ding; Lili Li; Peter Whyte
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

6.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes.

Authors:  Silvia C Galván; Martha Martínez-Salazar; Víctor M Galván; Rocío Méndez; Gibran T Díaz-Contreras; Moisés Alvarado-Hermida; Rogelio Alcántara-Silva; Alejandro García-Carrancá
Journal:  BMC Genomics       Date:  2011-11-25       Impact factor: 3.969

8.  Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Authors:  Heather Griffin; Yasmina Soneji; Romy Van Baars; Rupali Arora; David Jenkins; Miekel van de Sandt; Zhonglin Wu; Wim Quint; Robert Jach; Krzysztof Okon; Hubert Huras; Albert Singer; John Doorbar
Journal:  Mod Pathol       Date:  2015-05-08       Impact factor: 7.842

9.  Identifying protein phosphorylation sites with kinase substrate specificity on human viruses.

Authors:  Neil Arvin Bretaña; Cheng-Tsung Lu; Chiu-Yun Chiang; Min-Gang Su; Kai-Yao Huang; Tzong-Yi Lee; Shun-Long Weng
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes.

Authors:  Talha Abdul Halim; Ammad Ahmad Farooqi; Farrukh Zaman
Journal:  Cancer Cell Int       Date:  2013-06-17       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.